Innovation with Integrity

Bruker Investor Relations

Corporate Governance

Committees & Charters

Bruker Corporation has three Board Committees: the Audit Committee, the Compensation Committee, and the Nominating Committee.

The Audit Committee provides assistance to the board of directors in fulfilling its legal and fiduciary obligations with respect to matters involving the accounting, auditing, financial reporting and internal control functions of the Company and its subsidiaries. The Audit Committee works extensively with the independent auditors, pre-approves all audit and non-audit services provided to the Company by its independent auditors, reviews the performance of the independent auditors and replaces or terminates the independent auditors when circumstances warrant. The Audit Committee is also charged with establishing and monitoring procedures for:

  •         (i)  The receipt, retention or treatment of complaints received by the Company regarding accounting, internal accounting controls or auditing matters.
  •         (ii) The confidential submission by the Company's employees of concerns regarding questionable accounting or auditing matters.

The Compensation Committee administers the Company's stock option plan, determines the chief executive officer's salary, bonus, and equity based compensation, oversees the executive compensation program for the Company's other executive officers and determines such compensation, reviews general policy matters relating to compensation and employee benefits and makes recommendations concerning these matters to the board of directors.

The Nominating Committee assists the board in identifying and recruiting individuals qualified to become board members, consistent with criteria approved by the board, and to recommend to the board nominees for election to the office of director at the next annual meeting of stockholders, or for election to fill any vacancies between annual meetings. While the board of directors retains responsibility for selecting nominees and recommending them for election by the Company’s stockholders, the Nominating Committee is responsible for developing and implementing a process to identify qualified and willing candidates for recommendation to the board.

Chair Member

  Audit Committee Compensation Committee Nominating Committee
Frank H. Laukien, Ph.D
Cynthia M. Friend
Marc A. Kasnter, Ph.D
Jörg C. Laukien
William A. Linton, Ph.D
Gilles Martin, Ph.D
John Ornell
Richard Packer
Adelene Q. Perkins
Hermann Requardt, Ph.D
Robert Rosenthal, Ph.D

BRKR (Common Stock)

Stock Quote: NASD

Price $32.86

Change -0.97 (-2.87%)

11/12/18 04:00 PM Pricing delayed 20 minutes

Investor Contact

Miroslava Minkova
Head of Investor Relations
Bruker Corporation
P: +1 978 663 3660 x1479

Search Investor Relations